RETRACTED: CARDIOMETABOLIC DISORDERS AND UROLITHIASIS: PATHOGENESIS OF COMORBIDITY by G. G. Sharvadze, A. К. Kerimov, М. N. Mamedov

Get full text

PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE by M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva

Get full text

MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS by G. G. Sharvadze, R. R. Dalari, B. U. Mardanov, M. N. Mamedov

Get full text

Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease? by G. G. Sharvadze, M. N. Mamedov, E. A. Poddubskaya, D. G. Kurbatov

Get full text

HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE by G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov

Get full text